These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11354378)

  • 1. Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.
    Stutzmann JM; Bohme GA; Boireau A; Damour D; Debono MW; Genevois-Borella A; Jimonet P; Pratt J; Randle JC; Ribeill Y; Vuilhorgne M; Mignani S
    Bioorg Med Chem Lett; 2001 May; 11(9):1205-10. PubMed ID: 11354378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists.
    Mignani S; Bohme GA; Boireau A; Cheve M; Damour D; Debono MW; Genevois-Borella A; Imperato A; Jimonet P; Pratt J; Randle JC; Ribeill Y; Vuilhorgne M; Stutzmann JM
    Bioorg Med Chem Lett; 2000 Mar; 10(6):591-6. PubMed ID: 10741560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
    Stutzmann JM; Bohme GA; Boireau A; Damour D; Debono MW; Genevois-Borella A; Imperato A; Jimonet P; Pratt J; Randle JC; Ribeill Y; Vuilhorgne M; Mignani S
    Bioorg Med Chem Lett; 2000 May; 10(10):1133-7. PubMed ID: 10843235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.
    Pratt J; Jimonet P; Bohme GA; Boireau A; Damour D; Debono MW; Genevois-Borella A; Randle JC; Ribeill Y; Stutzmann JM; Vuilhorgne M; Mignani S
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2749-54. PubMed ID: 11133083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
    Jimonet P; Bohme GA; Bouquerel J; Boireau A; Damour D; Debono MW; Genevois-Borella A; Hardy JC; Hubert P; Manfré F; Nemecek P; Pratt J; Randle JC; Ribeill Y; Stutzmann JM; Vuilhorgne M; Mignani S
    Bioorg Med Chem Lett; 2001 Jan; 11(2):127-32. PubMed ID: 11206442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist.
    Mignani S; Bohme GA; Birraux G; Boireau A; Jimonet P; Damour D; Genevois-Borella A; Debono MW; Pratt J; Vuilhorgne M; Wahl F; Stutzmann JM
    Bioorg Med Chem; 2002 May; 10(5):1627-37. PubMed ID: 11886824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of 4,10-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives: highly potent and selective AMPA receptor antagonists with in vivo activity.
    Stutzmann JM; Vuilhorgne M; Mignani S
    Mini Rev Med Chem; 2004 Feb; 4(2):123-40. PubMed ID: 14965286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.
    Canton T; Böhme GA; Boireau A; Bordier F; Mignani S; Jimonet P; Jahn G; Alavijeh M; Stygall J; Roberts S; Brealey C; Vuilhorgne M; Debono MW; Le Guern S; Laville M; Briet D; Roux M; Stutzmann JM; Pratt J
    J Pharmacol Exp Ther; 2001 Oct; 299(1):314-22. PubMed ID: 11561094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists.
    Jimonet P; Chevé M; Bohme GA; Boireau A; Damour D; Debono MW; Genevois-Borella A; Imperato A; Pratt J; Randle JC; Ribeill Y; Stutzmann JM; Vuilhorgne M; Mignani S
    Bioorg Med Chem; 2000 Aug; 8(8):2211-7. PubMed ID: 11003165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2219-31. PubMed ID: 8667365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.
    Wang Y; Konkoy CS; Ilyin VI; Vanover KE; Carter RB; Weber E; Keana JF; Woodward RM; Cai SX
    J Med Chem; 1998 Jul; 41(14):2621-5. PubMed ID: 9651166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2232-44. PubMed ID: 8667366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists.
    Gitto R; De Luca L; Pagano B; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2008 Mar; 16(5):2379-84. PubMed ID: 18077172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.
    Inami H; Shishikura JI; Yasunaga T; Hirano M; Kimura T; Yamashita H; Ohno K; Sakamoto S
    Chem Pharm Bull (Tokyo); 2019; 67(7):699-706. PubMed ID: 31257325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
    Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
    J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.